• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

夜间高血压患者的睡眠呼吸暂停——捷克共和国的一项多中心研究。

Sleep apnoea in patients with nocturnal hypertension - a multicenter study in the Czech Republic.

作者信息

Hobzova M, Sonka K, Pretl M, Vaclavik J, Kriegova E, Radvansky M, Zapletalova J, Plackova M, Kolek V

机构信息

Department of Respiratory Medicine, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Olomouc, Czech Republic.

出版信息

Physiol Res. 2018 May 4;67(2):217-231. doi: 10.33549/physiolres.933570. Epub 2018 Jan 5.

DOI:10.33549/physiolres.933570
PMID:29303603
Abstract

Sleep apnoea (SA) is common in patients with hypertension. Nowadays, limited data on the prevalence of SA in nocturnal hypertension (NH) exist. Therefore, we studied the occurrence of SA in Czech patients and its association with 24-h ambulatory blood pressure monitoring (ABPM), breathing disturbances in sleep, anthropometric data, Mallampati score and Epworth sleepiness scale (ESS) using the Apnea Link device. Undiagnosed SA was found in 72.9 % patients (29.3 % mild, 26.6 % moderate, 17.0 % severe) of 188 patients with NH measured by ABPM. The median of the apnoea-hypopnoea index (AHI) was 12.0 (25th-75th percentile 5.0-23.8). Moderate/severe SA (AHI>/=15) was associated with BMI, waist circumference, mean night saturation (SpO(2)), t90, oxygen desaturation index (ODI), ESS (daytime BP only) (p</=0.032), but not ABPM parameters and Mallampati score (p>0.09). A likelihood of moderate/severe SA was enhanced by ODI>14.5 events/h (odds ratio=57.49, 95 % CI=22.79-145.01), t90>6.5 % (8.07, 4.09-15.92), mean night SpO(2)<93.5 % (3.55, 1.92-6.59), BMI>29.05 kg/m(2) (6.22, 3.10-12.49), circum waist>105.5 cm (3.73, 1.57-8.83), but not by any ABPM parameter. In conclusion, a high incidence of SA (72.9 %) was observed in Czech patients with NH. SA severity was associated with body characteristics and oxygenation parameters, but not with ABMP parameters and Mallampati score.

摘要

睡眠呼吸暂停(SA)在高血压患者中很常见。目前,关于夜间高血压(NH)患者中SA患病率的数据有限。因此,我们使用Apnea Link设备研究了捷克患者中SA的发生情况及其与24小时动态血压监测(ABPM)、睡眠呼吸紊乱、人体测量数据、马兰帕蒂评分和爱泼华嗜睡量表(ESS)的关系。通过ABPM测量的188例NH患者中,72.9%的患者发现了未诊断出的SA(轻度29.3%,中度26.6%,重度17.0%)。呼吸暂停低通气指数(AHI)的中位数为12.0(第25至75百分位数为5.0 - 23.8)。中度/重度SA(AHI≥15)与体重指数、腰围、夜间平均血氧饱和度(SpO₂)、t90、氧饱和度下降指数(ODI)、ESS(仅白天血压)相关(p≤0.032),但与ABPM参数和马兰帕蒂评分无关(p>0.09)。ODI>14.5次/小时(优势比=57.49,95%可信区间=22.79 - 145.01)、t90>6.5%(8.07,4.09 - 15.92)、夜间平均SpO₂<93.5%(3.55,1.92 - 6.59)、体重指数>29.05 kg/m²(6.22,3.10 - 12.49)、腰围>105.5 cm(3.73,1.57 - 8.83)会增加中度/重度SA的可能性,但与任何ABPM参数无关。总之,在捷克NH患者中观察到SA的高发病率(72.9%)。SA严重程度与身体特征和氧合参数相关,但与ABMP参数和马兰帕蒂评分无关。

相似文献

1
Sleep apnoea in patients with nocturnal hypertension - a multicenter study in the Czech Republic.夜间高血压患者的睡眠呼吸暂停——捷克共和国的一项多中心研究。
Physiol Res. 2018 May 4;67(2):217-231. doi: 10.33549/physiolres.933570. Epub 2018 Jan 5.
2
Prevalence of hypertension and circadian blood pressure variations in patients with obstructive sleep apnoea-hypopnoea syndrome.阻塞性睡眠呼吸暂停低通气综合征患者的高血压患病率及昼夜血压变化
J Int Med Res. 2014 Jun;42(3):773-80. doi: 10.1177/0300060513516756. Epub 2014 Mar 20.
3
Breathing Disturbances Without Hypoxia Are Associated With Objective Sleepiness in Sleep Apnea.无低氧血症的呼吸紊乱与睡眠呼吸暂停时的客观嗜睡相关。
Sleep. 2017 Nov 1;40(11). doi: 10.1093/sleep/zsx152.
4
Proteinuria is associated with sleep apnea in chronic kidney disease.蛋白尿与慢性肾脏病患者的睡眠呼吸暂停相关。
Nephrol Dial Transplant. 2016 May;31(5):772-9. doi: 10.1093/ndt/gfv306. Epub 2015 Aug 26.
5
At 68 years, unrecognised sleep apnoea is associated with elevated ambulatory blood pressure.在 68 岁时,未被识别的睡眠呼吸暂停与动态血压升高有关。
Eur Respir J. 2012 Sep;40(3):649-56. doi: 10.1183/09031936.00162710. Epub 2012 Apr 20.
6
[Analysis of clinical characteristics and risk factors of obstructive sleep apnea hypopnea syndrome with hypertension].[阻塞性睡眠呼吸暂停低通气综合征合并高血压的临床特征及危险因素分析]
Zhonghua Yi Xue Za Zhi. 2016 Mar 1;96(8):605-9. doi: 10.3760/cma.j.issn.0376-2491.2016.08.005.
7
Risk factors for, and prevalence of, sleep apnoea in cardiac rehabilitation facilities in Germany: The Reha-Sleep registry.德国心脏康复中心睡眠呼吸暂停的危险因素和流行情况:Reha-Sleep 登记研究。
Eur J Prev Cardiol. 2015 Jul;22(7):820-30. doi: 10.1177/2047487314537916. Epub 2014 May 30.
8
The predictors of central and obstructive sleep apnoea in haemodialysis patients.血液透析患者中枢性和阻塞性睡眠呼吸暂停的预测因素
Nephrol Dial Transplant. 2007 Apr;22(4):1190-7. doi: 10.1093/ndt/gfl748. Epub 2007 Feb 3.
9
Oxygen desaturation index from nocturnal oximetry: a sensitive and specific tool to detect sleep-disordered breathing in surgical patients.夜间血氧饱和度下降指数:一种用于检测外科手术患者睡眠呼吸障碍的敏感且特异的工具。
Anesth Analg. 2012 May;114(5):993-1000. doi: 10.1213/ANE.0b013e318248f4f5. Epub 2012 Feb 24.
10
The association of sleep disordered breathing with left ventricular remodeling in CAD patients: a cross-sectional study.冠心病患者睡眠呼吸障碍与左心室重构的关联:一项横断面研究。
BMC Cardiovasc Disord. 2017 Sep 18;17(1):250. doi: 10.1186/s12872-017-0684-1.

引用本文的文献

1
Long-Term Adherence in Overweight Patients with Obstructive Sleep Apnea and Hypertension-A Pilot Prospective Cohort Study.超重阻塞性睡眠呼吸暂停合并高血压患者的长期依从性——一项前瞻性队列研究试点
Diagnostics (Basel). 2023 Apr 17;13(8):1447. doi: 10.3390/diagnostics13081447.
2
Association and Risk Factors for Obstructive Sleep Apnea and Cardiovascular Diseases: A Systematic Review.阻塞性睡眠呼吸暂停与心血管疾病的关联及危险因素:一项系统综述。
Diseases. 2021 Dec 2;9(4):88. doi: 10.3390/diseases9040088.
3
Nocturnal hypertension in primary care patients with high office blood pressure: A regional study of the MAPAGE project.
基层医疗中诊室血压高的患者的夜间高血压:MAPAGE 项目的区域性研究。
J Clin Hypertens (Greenwich). 2020 Jun;22(6):991-1008. doi: 10.1111/jch.13903. Epub 2020 Jun 8.
4
Blood Pressure Non-Dipping and Obstructive Sleep Apnea Syndrome: A Meta-Analysis.血压非勺型变化与阻塞性睡眠呼吸暂停综合征:一项荟萃分析。
J Clin Med. 2019 Sep 2;8(9):1367. doi: 10.3390/jcm8091367.